Abbott Rapid Diagnostics PTY LTD.
Abbott Rapid Diagnostics PTY LTD, a subsidiary of the global healthcare leader Abbott Laboratories, is headquartered in Australia and operates extensively across the Asia-Pacific region. Founded in 2017, the company has quickly established itself in the diagnostics industry, focusing on rapid testing solutions that enhance patient care and streamline clinical workflows. Specialising in point-of-care testing, Abbott Rapid Diagnostics offers a range of innovative products, including tests for infectious diseases, cardiac markers, and metabolic conditions. Their unique approach combines cutting-edge technology with user-friendly designs, ensuring accurate results in a timely manner. With a strong market position, Abbott Rapid Diagnostics is recognised for its commitment to quality and reliability, contributing significantly to the advancement of diagnostic capabilities in healthcare settings. The company continues to achieve notable milestones, reinforcing its reputation as a leader in rapid diagnostics.
DitchCarbon Score
How does Abbott Rapid Diagnostics PTY LTD.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Abbott Rapid Diagnostics PTY LTD.'s score of 50 is higher than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Abbott Rapid Diagnostics PTY LTD., headquartered in Australia, currently does not report specific carbon emissions data for the most recent year, as no emissions figures are available. The company is a current subsidiary of Abbott Laboratories, which cascades its climate commitments and emissions data down to its subsidiaries. Abbott Laboratories has established various climate initiatives, including targets set through the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP). However, specific reduction targets or achievements for Abbott Rapid Diagnostics PTY LTD. have not been disclosed. As a subsidiary, Abbott Rapid Diagnostics is expected to align with the broader sustainability goals of Abbott Laboratories, which may include commitments to reduce greenhouse gas emissions across Scope 1, 2, and 3 categories. Nonetheless, without specific data or targets from Abbott Rapid Diagnostics, the details of their individual climate commitments remain unclear.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2010 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 578,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 691,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | - | - | - | - | - | - | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Abbott Rapid Diagnostics PTY LTD. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
